Massachusetts General Hospital & Harvard Medical School’s Recovery Research Institute (RRI) features findings from recently published research on CARD®, developed by Dominion Diagnostics

The Recovery Research Institute (RRI) at the Massachusetts General Hospital and Harvard Medical School is currently featuring the recently published CARD® research study Systematic Evaluation of “Compliance” to Prescribed Treatment Medications and “Abstinence” from Psychoactive Drug Abuse in Chemical Dependence Programs: Data from the Comprehensive Analysis of Reported Drugs in its monthly newsletter.

Read More
Dominion Diagnostics launches Kratom testing to address growing designer drug use trend

Dominion Diagnostics, a leading national provider of drug testing, medication monitoring, and clinical support services, launched new testing today that will detect Kratom use. Dominion’s Kratom assay will expand the company’s designer drug testing menu, which already includes detection of synthetic cannabinoids (Spice/K2) and synthetic cathinones (bath salts).

Read More